Leges, Monaliza B.
HRN: 26-40-77 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/22/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/22/2024
12/23/2024
IV
500mg
Now
S/P LSTCS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft TissueReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes